Aranesp darbepoetin alfa: Phase II data

In a U.S. Phase II trial in 141 breast cancer patients with chemotherapy-induced anemia, 200 µg once

Read the full 173 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE